Variation curve of the extreme temperature index. حسب Chengyuan Hao (21615653)

"…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …"

Fluctuation trend of the mean temperature index. حسب Chengyuan Hao (21615653)

"…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …"

Variation curve of the mean temperature index. حسب Chengyuan Hao (21615653)

"…Secondly, the daily minimum and maximum temperatures increased significantly, which were 0.395°C/10a and 0.200°C/10a respectively<b>—</b>less than the national mean. …"

Overexpression of TNFAIP9 alleviated the renal fibrosis caused by 5/6 Nx in C57 mice. حسب Ying Chen (9697)

Overexpression of TNFAIP9 remitted the renal inflammation caused by 5/6 Nx in C57 mice. حسب Ying Chen (9697)

Overexpression of TNFAIP9 inhibited the TGF-β-induced fibrosis in HK-2 cells. حسب Ying Chen (9697)

Overexpression of TNFAIP9 suppressed inflammation in mouse peritoneal macrophages caused by 5/6 Nx in C57 mice. حسب Ying Chen (9697)

TNFAIP9 expression was increased in mice with chronic kidney disease (CKD) induced by 5/6 nephrectomy (Nx). حسب Ying Chen (9697)

Overexpression of TNFAIP9 counteracted the renal damage caused by 5/6 Nx in C57 mice. حسب Ying Chen (9697)

Overexpression of TNFAIP9 inhibited the TNF-α-induced inflammation in HK-2 cells. حسب Ying Chen (9697)

(a) Lactate suppression by sequential re-insertion of cmpd at low concentration in Jurkat cells. حسب Samo Lešnik (21073880)

Risk Illustration. حسب Iftikhar Ali Ch (20783753)

"…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …"

Predictors of SCD. حسب Iftikhar Ali Ch (20783753)

"…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …"

Clinical outcomes. حسب Iftikhar Ali Ch (20783753)

"…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …"

Obesity and Depressed Ejection Fraction. حسب Iftikhar Ali Ch (20783753)

"…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …"

Kaplan Meier curve. حسب Iftikhar Ali Ch (20783753)

"…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR >  60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. …"

Study data. حسب Jie Liu (15128)

"…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …"

Summary of clinical outcomes after 9 months. حسب Jie Liu (15128)

"…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …"

Approval by the research ethics committee. حسب Jie Liu (15128)

"…</p><p> Methods </p><p>We conducted a single-center, retrospective study during the COVID-19 outbreak in China, from December 7, 2022, to January 31, 2023. …"

Dynamic characteristics of (A) FIB and (B) PCT between the survival and deceased groups of SFTS patients with HLH. حسب Bo Zhang (6559)